SGT-151 (CUMYL-PEGACLONE): 2025’s Cutting-Edge Synthetic Cannabinoid for

In 2025, the demand for next-generation synthetic cannabinoids has never been higher. Among the compounds gaining strong momentum in advanced research labs is SGT-151, also known by its chemical name CUMYL-PEGACLONE. With its unique gamma-carboline backbone, SGT-151 represents a structural evolution in cannabinoid design — offering distinct receptor interactions that make it highly valuable for receptor binding analysis, forensic toxicology, and neurochemical profiling.

🔬 What Is SGT-151?

SGT-151 is a third-wave synthetic cannabinoid, categorized by its non-indole, non-indazole structure, differentiating it from earlier generations like JWH-018 or AB-FUBINACA. The compound acts as a potent CB1 receptor agonist, making it a top choice in 2025 for research into endocannabinoid system modulation, psychoactive analog development, and designer drug detection.

⚠️ SGT-151 is strictly for laboratory research and forensic analysis only. Not intended for human consumption or clinical use.

🧪 2025 Key Highlights of SGT-151

Compound Name: CUMYL-PEGACLONE
Cannabinoid Class: Gamma-carboline synthetic cannabinoid
Potency: Strong CB1 activity with moderate CB2 response
Structure Advantage: More stable and metabolically predictable than indole-based cannabinoids
Use Cases:
- CB1/CB2 receptor mapping
- In vitro psychoactive modeling
- Designer cannabinoid metabolism profiling
- Forensic screening development

🌍 Why SGT-151 is Trending in 2025

In today’s cannabinoid research field, labs are shifting toward novel core structures that deliver targeted effects while staying compliant with emerging legal frameworks. SGT-151 is part of this evolution in cannabinoid pharmacology, offering benefits like:

🔬 Metabolic clarity: Known metabolites are easier to identify using mass spec and LC/MS analysis
📈 Low cross-reactivity: Doesn’t flag in older immunoassays — useful for new forensic testing models
🧠 Neuro-affinity: Strong affinity for central CB1 receptors, making it suitable for psychoactivity studies

🔍 Research Applications in 2025

SGT-151 is actively used in:

CB1/CB2 Receptor Binding Assays
In Silico & In Vitro Pharmacokinetic Studies
Comparative SAR (Structure-Activity Relationship) Research
Designer Drug Toxicology Reports
Synthetic Cannabinoid Classification Projects

Its gamma-carboline scaffold makes it one of the most interesting candidates in 2025 for modeling interaction profiles across cannabinoid receptor networks.

✅ Why Choose First Synthetic Chemical?

As a trusted provider of advanced research chemicals, First Synthetic Chemical supplies high-purity SGT-151 to institutions, toxicology labs, and licensed research facilities globally. When you order from us, you receive:

✅ Verified lab-tested compound
✅ Fast, discreet international shipping
✅ Secure packaging for chemical integrity
✅ Dedicated support for research professionals

🧬 Leading the Charge in Cannabinoid Science

SGT-151 isn’t just another cannabinoid — it’s a research-grade compound shaping how scientists study psychoactive receptors and metabolic pathways. Whether you’re working on detection protocols, pharmacological modeling, or structure evolution studies, SGT-151 offers a reliable, modern solution for 2025’s demanding research landscape.

📦 Order SGT-151 Today

Elevate your research with SGT-151 (CUMYL-PEGACLONE) — a proven choice for cannabinoid science in 2025. Explore its properties, gain insights into next-gen cannabinoid behavior, and push your lab’s data to the frontier of discovery.